FDAHealthMarch 13, 2025
Glenmark Pharmaceuticals Inc., USA — Clindamycin Hydrochloride Capsules, USP, 300mg, 100-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manu
⚠️ CGMP Deviations
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- March 13, 2025
U.S. Nationwide
What's affected?
- Product
- Clindamycin Hydrochloride Capsules, USP, 300mg, 100-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-144-01
- UPC
- 0368462142011
- Lot code
- 17241278
Additional details
Lot # 17241278, exp. date Jul-26 17241297, exp. date Jul-26 17241304, exp. date Jul-26 17241315, exp. date Jul-26 17241327, exp. date Jul-26
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: N/A.
Get Health recall alerts
Delivered to your inbox. Free. No account required.